ANGIOTENSIN RECEPTOR BLOCKERS (ARBs)
- Reduces HFrEF* mortality
- Reduces HFrEF * hospitalizations
- Lesser side effects like cough or angioedema
- Cost-effective, high-efficacy treatment option
Heart Failure with Reduced Ejection Fraction
NGIOTENSIN RECEPTOR BLOCKERS (ARBs)
like telmisartan are guideline-recommended treatments for heart
failure when the use of angiotensin-converting enzyme inhibitors
(ACEi) or angiotensin receptor-neprilysin inhibitors (ARNis)
are inappropriate or not feasible.
Telarb is telmisartan, a guideline-recommended antihypertensive
drug that is easy on the patient and easy on the pocket.